|
risperidone |
|
CHEBI:8871 |
|
A member of the class of pyridopyrimidines that is 2-methyl-6,7,8,9-tetrahydropyrido[1,2-a]pyrimidin-4-one carrying an additional 2-[4-(6-fluoro-1,2-benzoxazol-3-yl)piperidin-1-yl]ethyl group at position 2. |
|
 
This entity has been manually annotated by the ChEBI Team.
|
|
ChemicalBook:CB9131730, ChemicalBook:CB41565182, ChemicalBook:CB63154711, eMolecules:902418, Selleckchem:Risperidone(Risperdal), ZINC000000538312 |
|
Molfile
XML
SDF
|
|
|
|
InChI=1S/C23H27FN4O2/c1- 15- 18(23(29) 28- 10- 3- 2- 4- 21(28) 25- 15) 9- 13- 27- 11- 7- 16(8- 12- 27) 22- 19- 6- 5- 17(24) 14- 20(19) 30- 26- 22/h5- 6,14,16H,2- 4,7- 13H2,1H3 |
RAPZEAPATHNIPO-UHFFFAOYSA-N |
Cc1nc2CCCCn2c(=O)c1CCN1CCC(CC1)c1noc2cc(F)ccc12 |
|
EC 3.4.21.26 (prolyl oligopeptidase) inhibitor
Any EC 3.4.21.* (serine endopeptidase) inhibitor that interferes with the action of prolyl oligopeptidase (EC 3.4.21.26).
dopaminergic antagonist
A drug that binds to but does not activate dopamine receptors, thereby blocking the actions of dopamine or exogenous agonists.
serotonergic antagonist
Drugs that bind to but do not activate serotonin receptors, thereby blocking the actions of serotonin or serotonergic agonists.
alpha-adrenergic antagonist
An agent that binds to but does not activate alpha-adrenergic receptors thereby blocking the actions of endogenous or exogenous alpha-adrenergic agonists. alpha-Adrenergic antagonists are used in the treatment of hypertension, vasospasm, peripheral vascular disease, shock, and pheochromocytoma.
H1-receptor antagonist
H1-receptor antagonists are the drugs that selectively bind to but do not activate histamine H1 receptors, thereby blocking the actions of endogenous histamine.
|
|
dopaminergic antagonist
A drug that binds to but does not activate dopamine receptors, thereby blocking the actions of dopamine or exogenous agonists.
psychotropic drug
A loosely defined grouping of drugs that have effects on psychological function.
second generation antipsychotic
Antipsychotic drugs which can have different modes of action but which tend to be less likely than first generation antipsychotics to cause extrapyramidal motor control disabilities such as body rigidity or Parkinson's disease-type movements.
serotonergic antagonist
Drugs that bind to but do not activate serotonin receptors, thereby blocking the actions of serotonin or serotonergic agonists.
alpha-adrenergic antagonist
An agent that binds to but does not activate alpha-adrenergic receptors thereby blocking the actions of endogenous or exogenous alpha-adrenergic agonists. alpha-Adrenergic antagonists are used in the treatment of hypertension, vasospasm, peripheral vascular disease, shock, and pheochromocytoma.
H1-receptor antagonist
H1-receptor antagonists are the drugs that selectively bind to but do not activate histamine H1 receptors, thereby blocking the actions of endogenous histamine.
|
|
View more via ChEBI Ontology
3- {2- [4- (6- fluoro- 1,2- benzisoxazol- 3- yl)piperidin- 1- yl]ethyl}- 2- methyl- 6,7,8,9- tetrahydro- 4H- pyrido[1,2- a]pyrimidin- 4- one
|
risperidona
|
ChemIDplus
|
rispéridone
|
WHO MedNet
|
risperidone
|
KEGG DRUG
|
risperidonum
|
ChemIDplus
|
Risperdal
|
KEGG DRUG
|
Risperin
|
DrugBank
|
Rispolept
|
DrugBank
|
Rispolin
|
DrugBank
|
Sequinan
|
DrugBank
|
106266-06-2
|
CAS Registry Number
|
ChemIDplus
|
106266-06-2
|
CAS Registry Number
|
KEGG DRUG
|
4891881
|
Reaxys Registry Number
|
Reaxys
|
|